Updates are available Correction dated 2024-04-03
Click to view Correction: https://doi.org/10.1038/s41467-024-47288-3
-
Authors
Ferreira, Julio C. B. http://orcid.org/0000-0003-2694-239X
Campos, Juliane C.
Qvit, Nir
Qi, Xin http://orcid.org/0000-0002-9578-3890
Bozi, Luiz H. M.
Bechara, Luiz R. G.
Lima, Vanessa M.
Queliconi, Bruno B. http://orcid.org/0000-0001-7361-5573
Disatnik, Marie-Helene
Dourado, Paulo M. M.
Kowaltowski, Alicia J.
Mochly-Rosen, Daria http://orcid.org/0000-0002-6691-8733
- License Information
-
More Information
Article History
Received: 27 November 2017
Accepted: 18 December 2018
First Online: 18 January 2019
Change Date: 3 April 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-024-47288-3
Competing interests
: J.C.B.F and D.M.-R. are co-inventors of patent on “Antagonists of mitofusin 1 and beta II PKC association for treating heart failure”, PCT/US2019/062854. The remaining authors declare no competing interests.
